Received May 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Unknown | OT |
measles-like symptoms following vaccination; This spontaneous report was received from a consumer regarding a child patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 23-APR-2025, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), 0.5 mL administered intramuscularly as prophylaxis (lot number reported as 4015995, which is an invalid lot number for this product, expiration date reported as 24-SEP-2026) (vaccination scheme and anatomical site of injection were not reported). The vaccine was reconstituted with sterile diluent (BAXTER STERILE DILUENT) (lot # and expiration date were not reported). On 01-MAY-2025, the patient started to experience unusually severe measles-like symptoms (Measles) following the vaccination, such as runny nose and cough. On 04-MAY-2025, the patient experienced maculopapular rash covering most of the body. On 05-MAY-2025, the patient experienced 102 Fahrenheit degree (F) fever. On an unknown date in 2025, the patient tested negative for COVID and flu, and polymerase chain reaction (PCR) showed +. MeVa test result was pending. The outcome of measles-like symptoms was unknown. The causal relationship between the event and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) was not reported.
Diluent Mrk
Test Date: 20250504; Test Name: Fever; Result Unstructured Data: 102 [degF]; Test Date: 2025; Test Name: COVID test; Test Result: Negative ; Test Date: 2025; Test Name: Flu test; Test Result: Negative ; Test Date: 2025; Test Name: PCR; Result Unstructured Data: +